Atvogen OverviewRintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of chronic fatigue syndrome (CFS). There is low-strength evidence it can diminish CFS symptoms. It is an immunomodulatory double stranded RNA drug synthesized in the 1970s and manufactured by Hemispherx Biopharma. Although Ampligen was cleared for use in Canada in 1997, and obtained orphan drug status for treatment of CFS in the Eu...
Read more Atvogen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rintatolimod
Recent Atvogen Forums:Be the first to start a discussion about this drug.
Other drugs which contain Atvogen or a similar ingredient: (1 result)
- AMPLIGEN Atvogen